Comment by tosseraccount

"several thousand" is "list price" for single shots and no or fake health insurance. In practice insurance companies negotiate the price down and average patient pays much less than that. Major drug makers are ready to go the second the patents expire. Prices should drop dramatically for something like Humira (adalimumab) and biosimilars.